Approval · Notice of Compliance 6829 · 2005

PLAN B: Notice of Compliance 6829

Issued May 27, 2005

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 6829
Date: May 27, 2005
Company: Duramed Pharmaceuticals, Inc., A Subsidiary Of Barr Pharmaceuticals, Inc.
Product type: Nonprescription Pharmaceutical
Submission: Supplement to a New Drug Submission (SNDS), supplement
Submission class: Priority
Reason: Prescription to non-prescription switch
Therapeutic class: Emergency contraception

Products in this notice

Brand	DIN	Status today
PLAN B	Not yet assigned	—

Medicinal ingredients

LEVONORGESTREL 0.75 MG per TAB